GLAS (Glass House Brands) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)


GLAS Glass House Brands Inc GLAS
44 GF Score
Price $13.00
GF Value $6.46
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Glass House Brands 5-Year EBITDA Growth Rate?

Glass House Brands GLAS 44 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates GLAS with a GF Score™ of 44/100 and a GF Value™ of $6.46 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Glass House Brands's EBITDA per Share for the three months ended in Mar. 2026 was $-0.09.

During the past 12 months, Glass House Brands's average EBITDA Per Share Growth Rate was -100.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Glass House Brands was -50.80% per year. The lowest was -50.80% per year. And the median was -50.80% per year.

Glass House Brands  (NYSE:GLAS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Glass House Brands 5-Year EBITDA Growth Rate Related Terms

GLAS vs ZTS, UTHR: 5-Year EBITDA Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glass House Brands 5-Year EBITDA Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Glass House Brands's 5-Year EBITDA Growth Rate falls into.


GLAS
44GF Score
Glass House Brands Inc GLAS
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glass House Brands 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Glass House Brands (GLAS) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Glass House Brands and its competitors.
Is Glass House Brands' 5-Year EBITDA Growth Rate too high?
Glass House Brands' current 5-Year EBITDA Growth Rate is 0.00%. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' 5-Year EBITDA Growth Rate compare to ZTS and UTHR?
Glass House Brands' 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Drug Manufacturers company?
A good 5-Year EBITDA Growth Rate depends on the Drug Manufacturers industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Glass House Brands and its competitors. Glass House Brands's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.46, compared to a current price of $13.00 — trading 101.2% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Glass House Brands' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Glass House Brands (GLAS), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Glass House Brands (GLAS) Overvalued in 2026?

Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued. The current stock price of $13.00 is trading 101.2% above its estimated GF Value™ of $6.46. GuruFocus considers Glass House Brands to be Significantly Overvalued.

Key valuation signals for GLAS:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $6.46 vs. price of $13.00 (101.2% above fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Glass House Brands Business Description

Other Exchanges 4KF0:GermanyGLAS.A.U:Canada
Address 3645 Long Beach Boulevard, Long Beach, CA, USA, 90807
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score

Get the complete analysis for GLAS

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.00
Price
$6.46
GF Value